The University of Chicago Header Logo

Connection

Ming Xu to Imatinib Mesylate

Back to Details
This is a "connection" page, showing publications Ming Xu has written about Imatinib Mesylate.
Ming Xu
Connection Strength
0.139
Imatinib Mesylate
  1. Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia. Nat Med. 2017 Apr; 23(4):472-482.
    View in: PubMed
    Score: 0.139
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.